Apellis Pharmaceuticals Inc (APLS)
48.25
+0.79
(+1.66%)
USD |
NASDAQ |
May 06, 14:39
Apellis Pharmaceuticals Free Cash Flow: -595.51M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -595.51M |
| September 30, 2023 | -639.13M |
| June 30, 2023 | -624.61M |
| March 31, 2023 | -581.50M |
| December 31, 2022 | -515.27M |
| September 30, 2022 | -486.19M |
| June 30, 2022 | -500.56M |
| March 31, 2022 | -522.08M |
| December 31, 2021 | -564.23M |
| September 30, 2021 | -310.44M |
| June 30, 2021 | -245.03M |
| March 31, 2021 | -210.92M |
| December 31, 2020 | -165.91M |
| Date | Value |
|---|---|
| September 30, 2020 | -389.40M |
| June 30, 2020 | -339.91M |
| March 31, 2020 | -285.18M |
| December 31, 2019 | -212.83M |
| September 30, 2019 | -173.54M |
| June 30, 2019 | -153.08M |
| March 31, 2019 | -143.87M |
| December 31, 2018 | -131.24M |
| September 30, 2018 | -102.30M |
| June 30, 2018 | -80.30M |
| March 31, 2018 | -61.10M |
| December 31, 2017 | -46.60M |
Free Cash Flow Range, Past 5 Years
-639.13M
Minimum
Sep 2023
-153.08M
Maximum
Jun 2019
-395.54M
Average
-389.40M
Median
Sep 2020
Free Cash Flow Benchmarks
| Blueprint Medicines Corp | -452.91M |
| Sarepta Therapeutics Inc | -653.88M |
| Alnylam Pharmaceuticals Inc | 127.82M |
| Ionis Pharmaceuticals Inc | -335.52M |
| Madrigal Pharmaceuticals Inc | -325.71M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -97.88M |
| Cash from Investing (Quarterly) | 0.004M |
| Cash from Financing (Quarterly) | -3.913M |
| Free Cash Flow Per Share (Quarterly) | -0.8081 |
| Free Cash Flow to Equity (Quarterly) | -98.05M |
| Free Cash Flow to Firm (Quarterly) | -95.07M |
| Free Cash Flow Yield | -10.40% |